Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
- 23 December 2016
- journal article
- other
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 2 (1) , 10-15
Abstract
Optical biosensors entered target-based small-molecule drug discovery more than two decades ago and have since transformed into a value-adding component in the decision-making process. Here, we briefly highlight the major application areas of optical biosensors and focus on desirable profiles of such platforms in order to ensure their effective use in small molecule drug discovery. Furthermore, we will emphasize current technology-based constraints and discuss experimental strategies to address these limitations as well as provide a view of necessary technology improvements for next generation platforms.Keywords
Funding Information
- AstraZeneca
This publication has 29 references indexed in Scilit:
- Twenty years on: the impact of fragments on drug discoveryNature Reviews Drug Discovery, 2016
- Integrating biophysics with HTS-driven drug discovery projectsDrug Discovery Today, 2016
- Application of Optical Biosensors in Small-Molecule Screening ActivitiesSensors, 2012
- Biosensor-based small molecule fragment screening with biolayer interferometryJournal of Computer-Aided Molecular Design, 2011
- Affinity-based screening techniques: their impact and benefit to increase the number of high quality leadsExpert Opinion on Drug Discovery, 2010
- Fragment Library Screening and Lead Characterization Using SPR BiosensorsCurrent Topics in Medicinal Chemistry, 2009
- Label-Free Cell-Based Assays with Optical Biosensors in Drug DiscoveryASSAY and Drug Development Technologies, 2006
- Label-Free Assays on the BIND SystemSLAS Discovery, 2004
- Optical biosensors in drug discoveryNature Reviews Drug Discovery, 2002
- Implementing surface plasmon resonance biosensors in drug discoveryPharmaceutical Science & Technology Today, 2000